Group I (Control): |
Normal control rats received 0.2 mL saline (i.p.) injection for 10 days. |
Group II (Sham group): |
Rats were given a fake operation and received 0.2 mL saline (i.p.) injection for 10 days. |
Group III (VINCA S): |
Sham-treated rats received a single dose of VINCA (120 mg base/kg in a vehicle (1% carboxymethyl cellulose)) orally [34]. |
Group IV (VINCA M): |
Sham-treated rats received multiple oral doses of VINCA (30 mg base/kg) once daily for 6 days [34]. |
Group V (PTZ S): |
Sham-treated rats received a single dose of PTZ (160 mg/kg, i.p.) [57]. |
Group VI (PTZ M): |
Sham-treated rats received multiple doses of PTZ (40 mg/kg, orally) twice daily for 10 days [57]. |
Group VII (VINCA S + PTZ S): |
Sham-treated rats received a single dose of VINCA (120 mg base/kg) orally [34], and a single dose of PTZ (160 mg/kg) by (i.p.) injection [57]. |
Group VIII (VINCA M + PTZ M): |
Sham-treated rats received multiple doses of VINCA (30 mg base/kg, orally) once daily for 6 days [34], together with multiple doses of PTZ (40 mg/kg, orally) twice daily for 10 days [57]. |
Group IX (IRI): |
IRI rats received 0.2 mL saline by (i.p.) for 10 days. |
Group X (IRI + VINCA S): |
IRI treated rats received a single dose of VINCA (120 mg base/kg, orally) [34]. |
Group XI (IRI + VINCA M): |
IRI treated rats received multiple doses of VINCA (30 mg base/kg) once daily for 6 days orally [34]. |
Group XII (IRI + PTZ S): |
IRI treated rats received a single dose of PTZ (160 mg/kg, i.p.) [57]. |
Group XIII (IRI + PTZ M): |
IRI treated rats received multiple doses of PTZ (40 mg/kg, orally) twice daily for 10 days [57]. |
Group XIV (IRI + VINCA S + PTZ S): |
IRI treated rats received single dose of VINCA (120 mg base/kg) orally [34], together with a single dose of PTZ (160 mg/kg, i.p.) [57]. |
Group XV (IRI + VINCA M + PTZ M): |
IRI treated rats received multiple oral doses of VINCA (30 mg base/kg) once daily for 6 days [34], together with multiple oral doses of PTZ (40 mg/kg) twice daily for 10 days [57]. |
Group XVI (IRI + Montelukast): |
IRI treated rats were received single dose of Montelukast (10 mg/kg, i.p.) [50], used as a positive control group. |